510(k) Report

510(k) · Cleared

Cleared

Invader Factor II

K100943510(k) TraditionalCleared Jun 2, 2011422-day reviewClass II21 CFR 864.7280

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hologic, Inc. · NPR Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

Cleared on Jun 2, 2011 as substantially equivalent to K033612 (Roche Diagnostics Corp., 2003) after a 422-day review. Its family tree reaches back 1 generation to 2003.

Decided
Jun 2, 2011
Review
422 days
Class
Class II
Product code
NPR
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K033612 (2003). No later device cites it as a predicate yet.

K033612 · Factor II (Prothrombin) G20210A Kit · Roche Diagnostics Corp. · 2003 · recalled2000200220042006200820102012
  1. Root · 1 generation backK033612 Factor II (Prothrombin) G20210A KitRoche Diagnostics Corp. · 2003 · Recalled
  2. This deviceK100943 Invader Factor IIHologic, Inc. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K033612Factor II (Prothrombin) G20210A KitRoche Diagnostics Corp.20032
0 (this device)K100943Invader Factor IIHologic, Inc.2011—
FIG. 1 — Lineage of K100943, 2003–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NPR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NPR device

  1. #1 K250218 Xpert® FII & FVscore 9.5 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K033612Factor II (Prothrombin) G20210A Kit
Summary page 2
…e Information: I. Predicate device name(s): Factor 11 (Prothrombin) G20210OA, Roche 2. Predicate 510(kW number(s): Roche, K033612 3. Comparison with predicate: Product Name Factor II(rothrombin) 20210A Invader' Factor…
Roche Diagnostics Corp.20032

Also cleared against K033612: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 4 other devices also cite its predicate K033612.

How does its category compare?

All NPR devices

NPR Test, Factor Ii G20210a Mutations, Genomic Dna Pcr: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NPR

1in 2025

2011: 12018: 12023: 12025: 1
2007high 1 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NPR

Too few NPR 510(k)s in any year since 2007 to give a median.

Recalls per year · NPR

1in 2010

2009: 12010: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NPR

1in 2019

2008: 12010: 12018: 12019: 1
2007high 1 (2008) · low 0 (2007)2025

MAUDE reports naming product code NPR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20090—10
20100—11
20111—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—01
20190—01
20200—00
20210—00
20220—00
20231—00
20240—00
20251—00
20260—0—

What is it indicated for?

The Invader® Factor II test is an in vitro diagnostic test intended for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene in isolated genomic DNA obtained from whole blood potassium EDTA samples from patients with suspected thrombophilia.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K100943: Invader Factor II.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100943

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026